Burden of hepatitis B and C in Europe calls for political impetus to accelerate elimination efforts
- PMID: 37633674
- DOI: 10.1016/S2468-2667(23)00179-2
Burden of hepatitis B and C in Europe calls for political impetus to accelerate elimination efforts
Conflict of interest statement
I have served as an advisor or speaker for Abbott, AbbVie, GlaxoSmithKline, and Gilead. I acknowledge the use of DeepL Write to improve the syntax during the preparation of this work; after using this tool, I reviewed and edited the content as needed and take full responsibility for the content of the publication.
Comment on
-
Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019.Lancet Public Health. 2023 Sep;8(9):e701-e716. doi: 10.1016/S2468-2667(23)00149-4. Lancet Public Health. 2023. PMID: 37633679 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical